The U.S. Small Molecule Innovator API CDMO Market offers growth opportunities fueled by rising demand for HPAPIs across ...

NCoR1/RARα interaction was identified as a target for selective chaperone-mediated autophagy (CMA) inhibition in lung cancer.

Wegovy maker Novo Nordisk has hired the start-up Deep Apple Therapeutics to develop small molecules as its next weight-loss ...

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing life-science ...

Understanding how molecules interact is central to biology: from decoding how living organisms function to uncovering disease ...

A collaborative effort between Meta, Lawrence Berkeley National Laboratory and Los Alamos National Laboratory leverages Los ...

Researchers at the Massachusetts Institute of Technology and Recursion Pharmaceuticals Inc. have released an open-source AI ...

HepaRegeniX GmbH ("HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver disease ...

All around the Universe, clouds of gas and dust swirl between stars, hiding tiny, reactive molecules that could hold answers ...

Novo Nordisk and Deep Apple Therapeutics Inc. have entered a research collaboration and exclusive license agreement.

Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an unspecified up-front payment, research costs ...